FUNDC1 and Parkinson disease: Conversely, overexpression of FUNDC1 significantly improved locomotor function and extended survival in an ALS mouse model [104], with disrupted cardiolipin metabolism in both AD and PD potentially leading to mitochondrial synaptic dysfunction, oxidative stress, and neuroinflammation [105].